デフォルト表紙
市場調査レポート
商品コード
1569427

依存症治療の市場規模、シェア、成長分析、タイプ別、薬剤タイプ別、治療センター別、流通チャネル別、地域別 - 産業予測、2024年~2031年

Addiction Treatment Market Size, Share, Growth Analysis, By Type, By Drug Type, By Treatment Centers, By Distribution Channel, By Region - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
依存症治療の市場規模、シェア、成長分析、タイプ別、薬剤タイプ別、治療センター別、流通チャネル別、地域別 - 産業予測、2024年~2031年
出版日: 2024年10月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の依存症治療の市場規模は、2022年に51億米ドルとなり、2023年の54億米ドルから、2031年までには84億7,000万米ドルに成長し、予測期間(2024年~2031年)のCAGRは5.80%で成長する見通しです。

依存症治療市場は、依存症率の上昇、薬物意識向上への取り組み強化、予防プログラム、技術の進歩など、さまざまな要因が重なり、大きな拡大を見せています。政府の後押しや啓発キャンペーンにより、より多くの人々が治療を受けるようになっており、さまざまなメディアを通じて情報が入手できるようになったことも後押ししています。新しい薬や治療施設(特に民間の回復センター)の出現は、依存症の影響を受ける人口の増加に伴い、治療へのアクセスを広げています。市場成長の顕著な要因は、処方薬の誤用が世界的に急増していることです。啓発プログラムや禁煙治療に対する有利な償還政策など、政府の支援策が市場力学をさらに後押ししています。また、治療法や薬剤の絶え間ない技術革新も、依存症問題に対する一般市民の意識の高まりとともに、市場拡大を後押ししています。Cipla Inc.、Alkermes、Pfizer Inc.などの大手企業は、合併や提携を通じて革新的なソリューションに戦略的に投資しています。同市場は、アルコール、タバコ、オピオイド依存症など、さまざまな治療カテゴリーを包含していますが、中でもタバコ治療は、その健康への影響に対する意識の高まりから、最も急速な成長が見込まれています。さらに、治療施設ではワイヤレス技術が普及しつつあり、その中でもリハビリセンターは全人的なケア手法で市場をリードしています。アジア太平洋地域は、薬物乱用の増加、中間層の拡大、ヘルスケアへのアクセス強化に向けた政府の取り組みなどを背景に、最も高い成長が見込まれています。とはいえ、特に継続的なモニタリングと複数の介入を必要とする治療プロセスの長期化に関する課題が残っており、これが今後の市場成長を阻害する可能性があります。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主要な市場の考察

  • 技術分析
  • バリューチェーン分析
  • 市場のエコシステム
  • ケーススタディ分析
  • 規制情勢
  • イノベーションマトリクス
  • 主要な投資分析
  • 主要な成功要因
  • 競合の程度

依存症治療市場:タイプ別

  • 市場概要
  • アルコール依存症治療
  • タバコ / ニコチン依存症治療
  • オピオイド依存症治療
  • その他

依存症治療市場:薬剤タイプ別

  • 市場概要
  • ブプロピオン
  • バレニクリン
  • アカンプロサート
  • ジスルフィラム
  • ナルトレキソン
  • メサドン
  • ブプレノルフィン
  • ニコチン代替製品
  • その他

依存症治療市場:治療センター別

  • 市場概要
  • 住宅治療センター
  • 外来治療センター
  • 入院治療センター

依存症治療市場:流通チャネル別

  • 市場概要
  • 小売薬局
  • 病院薬局
  • オンライン薬局

依存症治療市場:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Alkermes plc(Ireland)
  • Dr. Reddy's Laboratories Ltd.(India)
  • Hikma Pharmaceuticals plc(UK)
  • Indivior PLC(UK)
  • Mallinckrodt Pharmaceuticals(Ireland)
  • Orexo AB(Sweden)
  • Pear Therapeutics(US)Inc.(US)
  • Pfizer Inc.(US)
  • Viatris Inc.(US)
  • American Addiction Centers, Inc.(US)
  • Quest Diagnostics, Inc.(US)
  • Sage Therapeutics, Inc.(US)
  • Gilead Sciences, Inc.(US)
  • Acadia Pharmaceuticals Inc.(US)
  • Medications for Addiction Treatment(MAT)(US)
  • Intra-Cellular Therapies, Inc.(US)
  • Emergent BioSolutions Inc.(US)
  • Hims & Hers Health, Inc.(US)
  • Lundbeck A/S(Denmark)
  • Cambrex Corporation(US)
  • Caron Treatment Centers(US)
  • Smart Recovery(US)
  • Recovery Brands(US)
目次
Product Code: SQMIG35J2121

Global Addiction Treatment Market size was valued at USD 5.1 billion in 2022 and is poised to grow from USD 5.4 billion in 2023 to USD 8.47 billion by 2031, growing at a CAGR of 5.80% during the forecast period (2024-2031).

The addiction treatment market is witnessing significant expansion driven by a confluence of factors, including rising addiction rates, enhanced drug awareness initiatives, preventive programs, and technological advancements. Government backing and awareness campaigns are prompting more individuals to pursue treatment, bolstered by the availability of information across various media. The emergence of new medications and treatment facilities-especially private recovery centers-has broadened access to care for an increasing population impacted by addiction. A notable contributor to market growth is the global surge in prescription medication misuse. Supportive government measures, including awareness programs and favorable reimbursement policies for smoking cessation therapies, are propelling market dynamics further. Continuous innovation in therapies and medications also promises to fuel expansion, alongside a growing public awareness of addiction issues. Major players like Cipla Inc., Alkermes, and Pfizer Inc. are strategically investing in innovative solutions through mergers and partnerships. The market encapsulates different treatment categories, such as alcohol, tobacco, and opioid addiction, with tobacco treatment poised for the most rapid growth due to heightened awareness of its health impacts. Moreover, wireless addiction treatment technologies are gaining traction within treatment facilities, with rehabilitation centers leading the way due to their holistic care methodologies. The Asia-Pacific region is anticipated to experience the highest growth, driven by increasing substance abuse, an expanding middle class, and governmental efforts to enhance healthcare access. Nonetheless, challenges remain, particularly concerning the lengthy nature of treatment processes that require ongoing monitoring and multiple interventions, which may inhibit future market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the global addiction treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global addiction treatment Market Segmental Analysis

Global Addiction Treatment Market is segmented by Type, Drug Type, Treatment Centers, Distribution Channel, and region. Based on Type, the market is segmented into Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, and Others. Based on Drug Type, the market is segmented into Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, Others. Based on Treatment Centers, the market is segmented into Residential Treatment Centers, Outpatient Treatment Centers, and Inpatient Treatment Centers. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global addiction treatment Market

The rising prevalence of substance abuse disorders globally is a significant market driver for the addiction treatment market. Increasing awareness about the health and social consequences of addiction is prompting more individuals to seek help, thereby boosting demand for various treatment options, including rehabilitation programs, counseling, and medication-assisted therapies. Additionally, the growing acceptance of mental health issues and the reduction of stigma surrounding addiction are fostering a supportive environment for those in need of treatment. This trend, coupled with advancements in therapeutic techniques and supportive digital platforms, is expected to drive the growth of the global addiction treatment market significantly.

Restraints in the global addiction treatment Market

The global addiction treatment market is likely to encounter significant restraints that may hinder its growth trajectory. The increasing legalization and widespread use of cannabis could lead to a misconception that substance abuse is less severe, potentially reducing demand for traditional addiction treatments. Furthermore, the expiration of patents for key pharmaceutical treatments may result in a rise in generic alternatives, affecting profitability for established companies in the sector. Additionally, the advancement of medical devices specifically designed for opioid addiction treatments may divert interest and resources from conventional therapies, further complicating the market landscape and stalling overall development and investment in addiction treatment solutions.

Market Trends of the global addiction treatment Market

The global addiction treatment market is increasingly shifting towards holistic and personalized care models, reflecting a broader understanding of addiction as a multifaceted issue that encompasses physical, mental, and social dimensions. This evolving market trend sees rehabilitation centers implementing tailored treatment plans that address individual patient needs, providing comprehensive support systems extending beyond traditional therapy and into aftercare. The integration of mental health services, community support, and innovative therapeutic options is enhancing accessibility and effectiveness of treatment. As a result, the sector is experiencing growth driven by a commitment to delivering well-rounded care that promotes lasting recovery and improved quality of life for individuals.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Case study Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Addiction Treatment Market by Type

  • Market Overview
  • Alcohol Addiction Treatment
  • Tobacco/Nicotine Addiction Treatment
  • Opioid Addiction Treatment
  • Others

Addiction Treatment Market by Drug Type

  • Market Overview
  • Bupropion
  • Varenicline
  • Acamprosate
  • Disulfiram
  • Naltrexone
  • Methadone
  • Buprenorphine
  • Nicotine Replacement Products
  • Others

Addiction Treatment Market by Treatment Centers

  • Market Overview
  • Residential Treatment Centers
  • Outpatient Treatment Centers
  • Inpatient Treatment Centers

Addiction Treatment Market by Distribution Channel

  • Market Overview
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Addiction Treatment Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Alkermes plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr. Reddy's Laboratories Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hikma Pharmaceuticals plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Indivior PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mallinckrodt Pharmaceuticals (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orexo AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pear Therapeutics (US) Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Viatris Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • American Addiction Centers, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quest Diagnostics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sage Therapeutics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gilead Sciences, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acadia Pharmaceuticals Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medications for Addiction Treatment (MAT) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Intra-Cellular Therapies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Emergent BioSolutions Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hims & Hers Health, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lundbeck A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cambrex Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Caron Treatment Centers (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smart Recovery (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Recovery Brands (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments